BDSX vs J · rev $71.3M vs P/E 36, $14.40B cap
Biodesix Inc (BDSX) versus Jacobs Solutions Inc. (J) — a side-by-side from cached financials, not a winner call.
Biodesix Inc (BDSX) is a diagnostics & research company listed on NASDAQ.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Latest reported BDSX revenue for 2024-12-31 was $71.3M. Net income was -$42.9M. Revenue was up 45.3% from 2023-12-31 to 2024-12-31. BDSX currently screens at market cap $157.6M.
J does not have a complete income-statement cache yet.
BDSX currently screens at market cap $157.6M. J currently screens at market cap $14.40B and trailing P/E 36.0.
Not investment advice. Open the BDSX and J stock pages for the full models.
Not investment advice.